Composition
- Active ingredients
- ESTROGENS, CONJUGATED SYNTHETIC A 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ESTROGENS, CONJUGATED SYNTHETIC A 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020992-005 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC A 0.9MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020992-003 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC A 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020992-001 · Discontinued
- ESTROGENS, CONJUGATED SYNTHETIC A 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- ESTROGENS, CONJUGATED SYNTHETIC A 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA020992-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020992.
At a glance
- Brand name
- Cenestin
- Active substance
- estrogens, conjugated synthetic a
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Aspen
- Status
- Discontinued
- FDA approval
- 24 Mar 1999
- Application
- NDA020992-004